Author
Reed F. Johnson
National Institutes of HealthORCID 0000-0002-4312-0550Unclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2024-2026 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 16 mutual co-author links4 papers
Recent·Most cited
- ImmunologybioRxivPreprint
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines
Breanna Kim, Rachel Roenicke, P J Roeder…·Mark Connors
This study compares intranasal and intramuscular vaccines, finding that the intranasal Ad4-S vaccine provides more durable and effective immune responses against SARS-CoV-2 in preclinical models.
1 citation - MicrobiologyPLoS PathogensPeer-reviewed
Intranasal parainfluenza virus-vectored vaccine expressing SARS-CoV-2 spike protein of Delta or Omicron B.1.1.529 induces mucosal and systemic immunity and protects hamsters against homologous and heterologous challenge
Hong-Su Park, Yumiko Matsuoka, Celia P. Santos…·Cyril Le Nouën
This study evaluates intranasal B/HPIV3 vaccines expressing SARS-CoV-2 spike proteins of different variants, showing they induce mucosal and systemic immunity and protect hamsters against homologous and heterologous challenges.
7 citationstop 5% - ImmunologyScience ImmunologyPeer-reviewed
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication
Paul J. Baker, Andrea C. Bohrer, Ehydel Castro…·Katrin D. Mayer-Barber
This study shows that pre-existing lung inflammation reduces SARS-CoV-2 replication by activating innate immune pathways, highlighting the role of the inflammatory microenvironment in controlling viral infection.
18 citationstop 3%